The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension
To access this article, please choose from the options below
Originally published online as doi:10.1053/j.ajkd.2006.07.009 on September 7, 2006.Support: None. Potential conflicts of interest: None.
PII: S0272-6386(06)01171-1
doi:10.1053/j.ajkd.2006.07.009
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
